Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

WHO Recommends Worldwide Use Of Rotavirus Vaccine For Children
To reduce an estimated half million deaths and two million hospitalizations from diarrhea caused by rotavirus each year, the WHO on Friday recommended that oral rotavirus vaccines be added to national childhood immunization programs, broadening access to the vaccine in the developing world,
generic viagra online
FDA Classifies Medtronic Voluntary February Recall For Intrepid™ Intervertebral Body Fusion Device As Class II
Medtronic, Inc. (NYSE: MDT) announced that the U.S. Food and Drug Administration (FDA) has classified its voluntary recall action of the Intrepid™ Intervertebral Body Fusion Device as a Class II recall. Medtronic initiated a voluntary recall of the product on February 6, 2009, and communicated the risk to physicians and hospitals. As of the date of this news release, all unused product has been retrieved and Medtronic has received confirmation of notification from all affected physicians and hospitals.
News of the day
GOP State Sens. Ask Bayh, Lugar To Oppose DOJ Nominee Johnsen; Senate Confirms FDA Head Hamburg
In a May 15 letter to Sens. Evan Bayh (D-Ind.) and Dick Lugar (R-Ind.), 31 Republican Indiana state senators asked the lawmakers to oppose the confirmation of Indiana University law professor Dawn Johnsen, President Obama"s nominee to head the Office of Legal Counsel in the Justice Department, due to her support for abortion rights, the AP/Milwaukee Journal Sentinel reports. The state senators wrote that Johnsen"s support for abortion rights "is more than simply pro-choice" and that "she is pro-choice in an extremely radical way," citing Johnsen"s statements and writings. The letter, which was signed by all but two of the state"s Republican senators, asked Bayh and Lugar to consider what Johnsen"s nomination "could mean for the future of the country." Indiana Senate President Pro Tem David Long (R) said, "It"s a statement from a very strong pro-life caucus," adding, "It is not based on the fact she is pro-choice, it is based on the fact that she is radically so." According to Long, the letter originated with a request from Indiana Right to Life to urge Bayh and Lugar to oppose Johnsen"s confirmation.Johnsen in an e-mail said that as a nominee she would not make public comments to the media. White House spokesperson Amy Brundage said that Johnsen "will bring unquestioned integrity and a commitment to non-partisan interpretation of the law to the Office of Legal Counsel, and we"re pleased that both of Indiana"s senators have expressed support for her nomination." Lugar spokesperson Andy Fisher on Monday in an e-mail said that although the senator has said he would not oppose Johnsen"s confirmation, Senate Democrats currently do not have enough support to move forward with the confirmation process. Bayh supports Johnsen"s confirmation, according to Bayh spokesperson Eric Kleiman (Smith, AP/Milwaukee Journal Sentinel, 5/18).Senate Confirms Hamburg as FDA CommissionerThe Senate on Monday by voice vote confirmed the nomination of Margaret Hamburg to be FDA commissioner, CQ HealthBeat reports (CQ HealthBeat, 5/18). According to the AP/Washington Post, Hamburg"s priorities include leading the development of a swine flu vaccine and overhauling the U.S. food safety system. During her confirmation hearing, Hamburg, a bioterrorism expert, said that she wants to increase consumer confidence in the agency by increasing transparency and accountability. Previously, Hamburg served as an assistant health secretary under President Clinton (AP/Washington Post, 5/19).
Endocrinology

Bovie Medical Corporation Announces 510K Submission To The FDA For Its BOSS Soft Tissue Coagulation Device

Bovie Medical Corporation (the "Company") (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, announced a 510K submission to the FDA seeking pre-market clearance for Bovie"s BOSS for surgical applications where soft tissue bipolar coagulation is desired. The BOSS is the latest generation device based on Bovie"s saline enhanced sintered steel technology. The BOSS delivers RF energy simultaneously with saline to perform coagulation of soft tissue and bone, with minimal smoke, charring and sticking of tissue as well as reduced blood loss. Saline enhanced surgeries reduce operating time while improving post-operative outcomes and shortens recovery time. The BOSS will primarily be targeted towards orthopedic hip and knee reconstruction surgeries, which are significant markets, with over 1.3 million procedures performed in the United States annually. These procedures represent large and growing markets due to a more active and aging population. The worldwide market is expected to exceed $500 million in 2009. Andrew Makrides, president of Bovie, stated, "In today"s economic environment, where controlling medical costs is important, the BOSS technology meets the needs of patients, surgeons and hospitals. Reduced blood loss, shortened operating and recovery time makes the BOSS a technology product that targets a large and growing market." For further information about the Company"s current and new products, please refer to the Investor Relations section of Bovie"s website http://www.boviemedical.com. Bovie Medical Corporation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009